HER2- / TRIPLE NEGATIVE C4161001
Study #C4161001Phase 1/2A Dose Escalation, Finding and Expansion Study Evaluation Safety, Tolerability, Pharmacokinetics, Pharacodynamics and Anti Tumore Activity of PF-07104091 as a Single Agent and in Combination Therapy
Back To Clinical Trials NCI Database Entry